Search results

Shares of Soleno Therapeutics SLNO have surged 56.4% over the past week, driven primarily by the announcement that Neurocrine Biosciences NBIX has entered into a definitive agreement with Soleno to

Investors in Soleno Therapeutics, Inc. SLNO need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $105 Call had some of the highest

• Shares of Soleno Therapeutics, Inc. (SLNO) surged 32.3% after Neurocrine Biosciences, Inc. (NBIX) agreed to buy the drugmaker for $2.9 billion, or $53 per share in cash.
• Shares of Micron